台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中化生

(1762)
可現股當沖
  • 股價
    45.15
  • 漲跌
    ▼0.10
  • 漲幅
    -0.22%
  • 成交量
    128
  • 產業
    上市 生技醫療類股
  • 253人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中化生 (1762)籌碼相關-福邦-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

福邦-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/07/0600.00193.0091.60-13,101-0.03%
2023/07/04195.5000.0094.8013,1420.03%
2023/06/09390.00392.6092.8003,8770.00%
2023/05/10199.501101.00102.5003,7560.00%
2023/05/0500.00199.6098.60-13,581-0.03%
2023/05/04298.80199.0098.1013,5290.03%
2023/04/27491.55691.6791.80-23,319-0.06%
2023/04/26290.0000.0089.9023,2700.06%
2023/04/06581.82782.4181.40-23,029-0.07%
2023/03/30180.6000.0079.0012,9380.03%
2023/03/291781.761682.8782.0012,7980.04%
2023/03/1500.00572.4072.90-52,856-0.18%
2023/03/141573.291074.1670.5052,7550.18%
2022/05/12259.90260.3056.7001,9780.00%
2022/04/2700.001261.8062.40-121,687-0.71%
2022/04/2200.002068.1266.90-201,548-1.29%
2022/04/2100.00169.0067.60-11,470-0.07%
2022/04/20167.602066.7066.70-191,327-1.43%
2022/04/181268.781267.1867.2001,1700.00%
2022/04/15166.70168.7064.6008920.00%
2022/04/14163.70164.2064.0007050.00%
2022/04/0800.001056.1056.10-10457-2.19%
2022/01/2400.001562.5062.60-15613-2.44%
2021/12/2800.003764.1764.40-37845-4.38%
2021/12/17165.202565.3465.30-24974-2.46%
2021/12/16166.3000.0065.8019940.10%
2021/12/1500.002066.1566.40-201,004-1.99%
2021/12/10667.3200.0066.9061,0330.58%
2021/12/092968.0600.0067.50291,0802.68%
2021/09/0700.001281.0080.70-121,751-0.69%
2021/09/0600.006085.2877.00-601,707-3.51%
2021/08/1200.002367.6067.90-231,217-1.89%
2021/06/1000.006064.6665.50-602,535-2.37%
2021/04/09261.002262.0662.00-20981-2.04%
2021/04/0100.002257.8558.30-22913-2.41%
2021/03/0800.002958.3258.20-291,053-2.75%
2021/02/1800.004054.5755.20-401,091-3.67%
2021/02/1700.001553.9053.80-151,102-1.36%
2021/01/2500.001755.9255.00-171,865-0.91%
2021/01/1800.001854.6554.60-181,861-0.97%
2020/12/073160.9400.0061.20314,5230.69%
2020/11/19364.3000.0064.4035,4110.06%
2020/11/099071.8400.0072.00905,3091.70%
2020/11/065569.3600.0070.50555,1891.06%
2020/11/057367.7900.0070.40735,1161.43%
2020/11/022064.0000.0063.60205,0400.40%
2020/10/291562.3000.0062.40155,0470.30%
2020/10/217060.6000.0061.20705,1691.35%
2020/10/193061.9300.0062.50305,1530.58%
2020/10/062071.1000.0070.00205,1810.39%
2020/10/053169.5000.0070.50315,1750.60%
2020/09/25676.60678.0067.8004,8990.00%
2020/09/1700.00167.0066.70-14,257-0.02%
2020/09/09267.50269.1566.4005,3360.00%
2020/09/08164.70165.7066.5005,0540.00%
2020/07/01165.50164.6064.60011,5260.00%
2020/06/18265.35166.0065.70110,7280.01%
2020/06/0200.0030154.4954.80-3019,892-3.04% 大賣/鉅額交易
2020/05/1800.00168.0066.20-17,945-0.01%
2020/05/14170.50470.1066.30-37,296-0.04%
2020/05/13467.5000.0069.0046,5200.06%
2020/05/0800.0049955.6255.60-4995,073-9.84% 大賣/鉅額交易
2020/05/0680066.7800.0061.008004,63217.27% 大買/鉅額交易
2020/05/0400.003053.7055.80-303,806-0.79%
2020/04/3000.004550.8050.80-453,720-1.21%
2020/04/152537.8900.0037.90252,7740.90%
2020/03/275031.9100.0031.60502,4382.05%
2019/07/2900.00135.9035.00-11,696-0.06%
2019/07/26135.3500.0035.3511,6600.06%
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章